The Molecular Footprint of Temozolomide: A Genomic Signature Unmasking the Origin of a Secondary Renal Cell Carcinoma (T&E Case Study)

Innovation Spotlight Speaker(s)

• 

  Ting Zhao, MD

  Pathology Fellow
  Massachusetts General Hospital
  BOSTON, Massachusetts, United States